Biologics Neuro InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™ byJosh SandbergJanuary 25, 2017
Biologics InVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital byJosh SandbergJanuary 11, 2017
Biologics Hospitals InVivo Therapeutics Responds to PixarBio Announcement byJosh SandbergJanuary 3, 2017
Neuro InVivo Therapeutics Announces Fifth Patient Conversion in INSPIRE Study of the Neuro-Spinal Scaffold™ byJosh SandbergAugust 17, 2016
Neuro Pamela Stahl appointed chief commercial officer of InVivo Therapeutics byJosh SandbergAugust 16, 2016
Biologics InVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study byJosh SandbergJuly 18, 2016
Spine InVivo Therapeutics touts case study in 1st spine scaffold implant byJosh SandbergJune 24, 2016
Spine InVivo’s pilot study expands to 10 spinal cord injury patients — 5 key notes byJosh SandbergOctober 21, 2015
